A large review described obesity as a systemic driver of cellular stress, linking overnutrition to unfolded protein response and oxidative and inflammatory signaling pathways, including NRF2. The report frames obesity-related risk through disruptions in intracellular quality-control systems rather than simply excess fat accumulation. In early detection, two related newborn screening studies point toward population-scale genomic risk discovery using dried blood spots. One analysis in Nature Communications examined whether newborn dried blood spot genomes can identify inherited variants associated with childhood cancers, while another study led by Dana-Farber/Boston Children’s and Mass General Brigham assessed genomic newborn screening for early-life cancer risk. Separately, proteomics work suggested carboxypeptidase E (CPE) as a potential biomarker for synucleinopathies, adding to the growing emphasis on molecular signature-based diagnostics. Collectively, these items emphasize moving risk detection upstream—either at birth or at the level of molecular pathways that precede clinical disease.